Cargando…
CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K3
BACKGROUND: Circular RNA (circRNA) is recently found to participate in the regulation of tumor progression, including ovarian cancer. However, the application of circRNA SET domain bifurcated histone lysine methyltransferase 1 (circSETDB1) as a therapeutic target in serous ovarian cancer (SOC) remai...
Autores principales: | Li, Bo, Zhang, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597278/ https://www.ncbi.nlm.nih.gov/pubmed/34789310 http://dx.doi.org/10.1186/s13048-021-00875-0 |
Ejemplares similares
-
Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer
por: Wang, Wei, et al.
Publicado: (2019) -
Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation
por: Wu, Milu, et al.
Publicado: (2018) -
Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming
por: Torrano, Joachim, et al.
Publicado: (2019) -
Knockdown of circ‐RAD23B inhibits non‐small cell lung cancer progression via the miR‐142‐3p/MAP4K3 axis
por: Zhuang, Qingyang, et al.
Publicado: (2022) -
Regulation and bioinformatic analysis of circ_0015891/miR-129-1-3p axis in methamphetamine-induced dopaminergic apoptosis
por: Deng, Bingpeng, et al.
Publicado: (2022)